Spine News and Research

RSS

Women using DMPA experience high BMD loss, researchers say

Nearly half of women using depot medroxyprogesterone acetate (DMPA), commonly known as the birth control shot, will experience high bone mineral density (BMD) loss in the hip or lower spine within two years of beginning the contraceptive, according to researchers at the University of Texas Medical Branch at Galveston.

22 Dec 2009

Investigation of IDH1 gene mutations in brain cancer receives new funds

Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the emerging field of cancer metabolism, announced today that it has received funding from Accelerate Brain Cancer Cure (ABC2), a non-profit organization that supports brain cancer research. ABC2’s funding will enable new research investigating IDH1 gene mutations in brain cancer, with the goal of supplementing Agios’s ongoing research into the development of new IDH1 therapeutics and diagnostics.

21 Dec 2009

Medtronic launches its SOVEREIGN Spinal System in the U.S.

Medtronic, Inc. today announced the U.S. launch of the SOVEREIGN™ Spinal System.

18 Dec 2009

European CHMP announces positive opinion for Amgen's Prolia marketing authorization

Amgen Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has announced a positive opinion for the marketing authorization of Prolia((TM)) (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.

18 Dec 2009

Interleukin Genetics introduces the Bone Health Genetic Test

Interleukin Genetics, Inc. announced today availability of the Bone Health Genetic Test designed to detect genetic patterns associated with the development of osteoporosis-related outcomes. The test determines an individual's risk for developing vertebral or spinal fractures and low bone mineral density.

17 Dec 2009

CDI purchases third FONAR UPRIGHT Multi-Position MRI

FONAR Corporation, The Inventor of MR Scanning, announced today that the Center for Diagnostic Imaging (CDI) (Minneapolis, MN) has purchased a third FONAR UPRIGHT® Multi-Position™ MRI. It is scheduled to be installed in CDI's OpenScan MRI center in Duluth, Minnesota, replacing the current low-field open-sided MRI scanner in that center.

17 Dec 2009

National medical societies launch multi-state advertising campaign to oppose current health care bill

Today, a group of national medical societies launched a multi-state advertising campaign in opposition to H.R. 3590, the Patient Protection and Affordable Care Act, currently under consideration by the U.S. Senate and making its way towards a final vote in the coming days.

17 Dec 2009

Pillo1 for chronic neck and back pain

At a time when Americans spend over $50 billion on ways to alleviate neck and back pain, Dr. Raymond Hall is theorizing a painful connection between conventional pillows and neck issues and created a revolutionary solution called Pillo1 (www.pillo1.com) to address the problem.

16 Dec 2009

MERI's EMS disaster training courses to be offered to paramedics and EMTs

The Medical Education and Research Institute (MERI) announced today the first of its EMS disaster training courses which will be offered to paramedics and EMTs throughout Memphis, Shelby County and its municipalities on December 17, 2009.

16 Dec 2009

Ouroboros Medical receives approval to market its spinal fusion product in Europe

Ouroboros Medical, Inc., an early stage medical device company focused on developing minimally invasive spine products for degenerated disc disease, has received approval to market Ouroboros’s spinal fusion product in Europe.

16 Dec 2009

NREF supports new post-residency fellowship grant program

The NREF has reached an agreement with Codman & Shurtleff, Inc. to provide funding to the NREF in support of the Foundation's new post-residency fellowship grant program.

16 Dec 2009

Spinal Restoration receives FDA SPA concurrence letter for its Phase 3 Biostat System study

Spinal Restoration, Inc. announced today it has received a Special Protocol Assessment concurrence letter from the U.S. Food and Drug Administration (FDA) for the design of its Phase 3 study of the Biostat System for the treatment of chronic discogenic low back pain.

15 Dec 2009

Cellular and subcellular effects of PACE technology presented

SANUWAVE Health, Inc., (www.sanuwave.com), an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, announced that the cellular and subcellular effects of PACE™ technology were described during a lecture presented this past weekend.

15 Dec 2009

NAMS recommends women to discuss osteoporosis with their OB/GYNs

According to a new survey distributed by The North American Menopause Society (NAMS), while 98 percent of women who participated consider bone strength to be an important health concern, nearly half (45 percent) of these women reported that osteoporosis was not addressed during their last routine OB/GYN visit, and more than a quarter (26.4 percent) of women surveyed have never discussed osteoporosis with their OB/GYN.

14 Dec 2009

Proteins from catfish venom glands could accelerate wound healing in humans

Lest anyone have concerns about attacks of killer catfish, rest assured that, at least in North America, these finned fatales use their venom mainly to defend themselves against predatory fish, though they can inflict a painful sting that many fishermen have suffered. In other parts of the world, some catfish do have extremely toxic venoms that can be deadly to humans.

11 Dec 2009

New data suggests bisphosphonate drug may play a role in reducing recurrent breast cancer

Bisphosphonates are routinely given to women with postmenopausal breast cancer, but new data suggests that these agents may play a role in reducing recurrent breast cancer as well.

11 Dec 2009

Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer

AstraZeneca (NYSE: AZN) today announced that data from a Phase III study of postmenopausal women with hormone receptor-positive advanced breast cancer presented at the San Antonio Breast Cancer Symposium (Abstract 25) showed treatment with fulvestrant (FASLODEX) 500 mg reduced the risk of disease progression (assessed as time to progression (TTP)) by 20%

11 Dec 2009

St. Luke's Hospital acquires computer-assisted surgery system from BrainLAB

BrainLAB, a manufacturer of software-driven systems for targeted, less-invasive medical treatments, announced today that St. Luke's Hospital in Cedar Rapids, Iowa, has acquired VectorVision® flex, a powerful computer-assisted surgery (CAS) system featuring Digital Lightbox© with TraumaCad(TM), a pre-operative planning and digital templating software solution.

9 Dec 2009

Osteologix to file an European Marketing Application for its NB S101 strontium therapy

Osteologix Inc. announced today that the company anticipates that it will be prepared to file a marketing application in 2011 in the European Union for its proprietary second-generation strontium therapy, NB S101 (strontium malonate). If successful, this will be Osteologix' first marketing approval of NB S101 for the treatment of postmenopausal osteoporosis.

9 Dec 2009

Global Health Partner starts up business for obesity treatment in Prague

Global Health Partner has started up a business for the treatment of obesity in Prague, and the first obesity operations have now been performed.

9 Dec 2009

Spine News and Research

Women using DMPA experience high BMD loss, researchers say

Investigation of IDH1 gene mutations in brain cancer receives new funds

Medtronic launches its SOVEREIGN Spinal System in the U.S.

European CHMP announces positive opinion for Amgen's Prolia marketing authorization

Interleukin Genetics introduces the Bone Health Genetic Test

CDI purchases third FONAR UPRIGHT Multi-Position MRI

National medical societies launch multi-state advertising campaign to oppose current health care bill

Pillo1 for chronic neck and back pain

MERI's EMS disaster training courses to be offered to paramedics and EMTs

Ouroboros Medical receives approval to market its spinal fusion product in Europe

NREF supports new post-residency fellowship grant program

Spinal Restoration receives FDA SPA concurrence letter for its Phase 3 Biostat System study

Cellular and subcellular effects of PACE technology presented

NAMS recommends women to discuss osteoporosis with their OB/GYNs

Proteins from catfish venom glands could accelerate wound healing in humans

New data suggests bisphosphonate drug may play a role in reducing recurrent breast cancer

Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer

St. Luke's Hospital acquires computer-assisted surgery system from BrainLAB

Osteologix to file an European Marketing Application for its NB S101 strontium therapy

Global Health Partner starts up business for obesity treatment in Prague

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News